Edition:
Deutschland

Fresenius SE & Co KGaA (FREG.DE)

FREG.DE on Xetra

32.37EUR
28 Oct 2020
Change (% chg)

€-1.03 (-3.08%)
Prev Close
€33.40
Open
€33.04
Day's High
€33.04
Day's Low
€32.01
Volume
2,407,505
Avg. Vol
1,792,453
52-wk High
€51.54
52-wk Low
€24.25

About

Fresenius SE & Co KGaA is a Germany-based healthcare group. It operates through four business segments. Fresenius Medical Care runs a global network of dialysis clinics, providing treatment for patients with chronic kidney failure. It also offers dialyzers, dialysis machines and renal pharmaceuticals. Fresenius Kabi specializes... (more)

Buy/Sell

Sell Hold Buy
1.91 Mean rating from 23 analysts

Overall

Beta: 0.56
Market Cap(Mil.): €39,028.29
Shares Outstanding(Mil.): 554.54
Dividend: 0.62
Yield (%): 0.88

FACTBOX-Drugmakers rush to develop COVID-19 treatments

(Updates AstraZeneca, Gilead and Vir) Oct 12 Drugmakers around the world are rushing to develop treatments for COVID-19, the respiratory disease caused by the novel coronavirus that has killed hundreds of thousands. Several companies are developing antibody treatments, similar to Regeneron Pharmaceutical Inc's treatment given to U.S. President Donald Trump for his COVID-19 infection. The following is a list of major companies that are developing treatments. For a separate F

Photo

In row with Tiffany, LVMH may find that most sales are final

France's LVMH faces an uphill battle in walking away from its $16 billion(12.32 billion pounds) deal to buy U.S. jeweler Tiffany & Co , with legal experts noting most mergers which end up in court are renegotiated rather than dissolved. | Video

ANALYSIS-In row with Tiffany, LVMH may find that most sales are final

Sept 18 France's LVMH faces an uphill battle in walking away from its $16 billion deal to buy U.S. jeweler Tiffany & Co, with legal experts noting most mergers which end up in court are renegotiated rather than dissolved.

Photo

Tech sector tightens its grip over Europe's stock markets

LONDON/MILAN Surging technology stocks are increasing their influence over European stock markets, with Prosus poised to snatch a key spot in the continent's leading index.

Photo

Tech sector tightens its grip over Europe's stock markets

LONDON/MILAN Surging technology stocks are increasing their influence over European stock markets, with Prosus poised to snatch a key spot in the continent's leading index.

Tech sector tightens its grip over Europe's stock markets

LONDON/MILAN, Sept 2 Surging technology stocks are increasing their influence over European stock markets, with Prosus poised to snatch a key spot in the continent's leading index.

Photo

Fresenius cuts 2020 outlook on pandemic impact

German healthcare group Fresenius cut its 2020 profit and revenue targets on Thursday as the COVID-19 pandemic hit elective procedures and delayed product launches, outweighing a strong performance in dialysis.

UPDATE 3-Fresenius cuts 2020 outlook on pandemic impact

* Shares down 4% (Adds details from conference call, updates shares)

Fresenius Medical Care reports second-quarter beat as pandemic effects ease

German dialysis specialist Fresenius Medical Care beat second-quarter net income expectations on Thursday, citing lower negative impact of the coronavirus pandemic compared to the previous quarter and strong underlying business performance.

Märkte

  • U.S.
  • Europa
  • Asien
  • Branchen

Branchenüberblick

Energie -0.20%
Rohstoffe -0.12%
Industrie -0.14%
Konjunktur abhängige Waren & Dienstleistungen +0.03%
Konjunktur unabhängige Waren & Dienstleistungen -0.03%
Finanzindustrie -0.02%
Pharma +0.02%
Technologie +0.00%